Baker Bros. Advisors CABA Position
Exited6-Fund ConvergenceBaker Bros. Advisors exited their position in Cabaletta Bio, Inc. (CABA) in Q2 2024, after holding the stock for 6 quarters.
The position was first reported in Q1 2023 and has been tracked across 6 quarterly 13F filings.
CABA is a convergence signal: 6 specialist biotech funds hold this stock, suggesting high institutional conviction.
Baker Bros. Advisors CABA Position History
Frequently Asked Questions
Does Baker Bros. Advisors own CABA?
No. Baker Bros. Advisors exited their position in Cabaletta Bio, Inc. (CABA) in Q2 2024. They previously held the stock for 6 quarters.
How many hedge funds own CABA?
6 specialist biotech hedge funds currently hold CABA, including Deerfield Management, Perceptive Advisors, Cormorant Asset Management and 3 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Baker Bros. Advisors first buy CABA?
Baker Bros. Advisors's position in CABA was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Baker Bros. Advisors's CABA position increasing or decreasing?
Baker Bros. Advisors completely exited their CABA position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
CABACompany Page →
All fund holders, insider trades, catalysts, and cash runway
Baker Bros. AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →